- Home
- BWAY vs QTRX Comparison
BWAY vs QTRX Comparison
Compare BWAY & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- QTRX
- Stock Information
- Founded
- BWAY 2003
- QTRX 2007
- Country
- BWAY Israel
- QTRX United States
- Employees
- BWAY N/A
- QTRX N/A
- Industry
- BWAY Medical/Dental Instruments
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- BWAY Health Care
- QTRX Industrials
- Exchange
- BWAY Nasdaq
- QTRX Nasdaq
- Market Cap
- BWAY 280.7M
- QTRX 241.2M
- IPO Year
- BWAY 2019
- QTRX 2017
- Fundamental
- Price
- BWAY $15.44
- QTRX $7.29
- Analyst Decision
- BWAY Strong Buy
- QTRX Hold
- Analyst Count
- BWAY 2
- QTRX 3
- Target Price
- BWAY $20.50
- QTRX $10.33
- AVG Volume (30 Days)
- BWAY 65.4K
- QTRX 770.2K
- Earning Date
- BWAY 11-11-2025
- QTRX 11-10-2025
- Dividend Yield
- BWAY N/A
- QTRX N/A
- EPS Growth
- BWAY 213.09
- QTRX N/A
- EPS
- BWAY 0.13
- QTRX N/A
- Revenue
- BWAY $49,094,000.00
- QTRX $130,203,000.00
- Revenue This Year
- BWAY N/A
- QTRX N/A
- Revenue Next Year
- BWAY N/A
- QTRX $37.03
- P/E Ratio
- BWAY $47.75
- QTRX N/A
- Revenue Growth
- BWAY 27.08
- QTRX N/A
- 52 Week Low
- BWAY $7.84
- QTRX $4.05
- 52 Week High
- BWAY $17.92
- QTRX $13.01
- Technical
- Relative Strength Index (RSI)
- BWAY 48.93
- QTRX 76.17
- Support Level
- BWAY $14.27
- QTRX $5.83
- Resistance Level
- BWAY $15.56
- QTRX $5.79
- Average True Range (ATR)
- BWAY 0.82
- QTRX 0.43
- MACD
- BWAY -0.10
- QTRX 0.22
- Stochastic Oscillator
- BWAY 51.44
- QTRX 97.70
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.